Prebet, T., & Zeidan, A. (2016). Trends in clinical investigation for myelodysplastic syndromes. Clinical Lymphoma Myeloma and Leukemia, 16, 57–63.
Article
Google Scholar
Greenberg, P. L., Stone, R. M., Al-Kali, A., Barta, S. K., Bejar, R., Bennett, J. M., et al. (2017). Myelodysplastic syndromes, version 2.2017, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 15(1), 60–87.
Article
Google Scholar
O'Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., et al. (2017). Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 15(7), 926–957.
Article
Google Scholar
Morel, T., & Cano, S. J. (2017). Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures. Orphanet Journal of Rare Diseases, 12(1), 171.
Article
Google Scholar
Anderson, M., & McCleary, K. K. (2015). From passengers to co-pilots: Patient roles expand. Science Translational Medicine, 7(291), 291fs25.
Article
Google Scholar
Bartlett, S. J., Barnes, T., & McIvor, R. A. (2014). Integrating patients into meaningful real-world research. Annals of the American Thoracic Society, 11(Suppl 2), S112–S117.
Article
Google Scholar
Boutin, M., Dewulf, L., Hoos, A., Geissler, J., Todaro, V., Schneider, R. F., et al. (2017). Culture and process change as a priority for patient engagement in medicines development. Therapeutic Innovation & Regulatory Science, 51(1), 29–38.
Article
Google Scholar
Sabino, G., Mills, A., Jonker, A., Lau, L., & Ayme, S. (2016). Patient-centered outcome measures in the field of rare diseases. International Rare Diseases Research Consortium.
European Medicines Agency: Committee for Medicinal Products for Human Use (2016) Appendix 2 to the guidelines on the evaluation of anticancer medicinal products in man.
Google Scholar
Center for Drug Evaluation and Research (2017) Application #208447Orig1s000: Multi-discipline review.
Google Scholar
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. JNCI: Journal of the National Cancer Institute, 85(5), 365–376.
Article
CAS
Google Scholar
Gnanasakthy, A., Mordin, M., Clark, M., DeMuro, C., Fehnel, S., & Copley-Merriman, C. (2012). A review of patient-reported outcome labels in the United States: 2006 to 2010. Value Health, 15(3), 437–442.
Article
Google Scholar
DeMuro, C., Clark, M., Doward, L., Evans, E., Mordin, M., & Gnanasakthy, A. (2013). Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010). Value Health, 16(8), 1150–1155.
Article
Google Scholar
Kulis, D., Bottomley, A., Whittaker, C., van de Poll-Franse, L., Darlington, A., Holzner, B., et al. (2017). The use of the EORTC item library to supplement EORTC quality of life instruments. Value Health, 20(9), A775.
Article
Google Scholar
Food and Drug Administration. (2014). Roadmap to patient-focused outcome measurement in clinical trials. Federal Register.
Morse, J. M. (2005). Evolving trends in qualitative research: Advances in mixed-method design. Qualitative Health Research, 15(5), 583–585.
Article
Google Scholar
Walton, M. K., Powers, J. H., 3rd, Hobart, J., Patrick, D., Marquis, P., Vamvakas, S., et al. (2015). Clinical outcome assessments: Conceptual foundation-report of the ISPOR clinical outcomes assessment - emerging good practices for outcomes research task force. Value Health, 18(6), 741–752.
Article
Google Scholar
US Department of Health and Human Services. Guidance for industry (2013) patient-reported outcome measures: Use in medical product development to support labeling claims. 2009. Online Source.
Google Scholar
US Food and Drug Administration (2017) Drug development tools qualifiation programs.
Google Scholar
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., et al. (1982). Toxicity and response criteria of the eastern cooperative oncology group. American Journal of Clinical Oncology, 5(6), 649–655.
Article
CAS
Google Scholar
Basch, E., Artz, D., Dulko, D., Scher, K., Sabbatini, P., Hensley, M., et al. (2005). Patient online self-reporting of toxicity symptoms during chemotherapy. Journal of Clinical Oncology, 23(15), 3552–3561.
Article
Google Scholar
Blair J, Presser S (eds) (1993) Survey procedures for conducting cognitive interviews to pretest questionnaires: A review of theory and practice. Proceedings of the section on survey research methods, annual meetings of the American statistical association, American statistical association Alexandria, VA.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.
Article
Google Scholar
Thomas, D. R. (2006). A general inductive approach for analyzing qualitative evaluation data. American Journal of Evaluation, 27(2), 237–246.
Article
Google Scholar
Bryman, A., & Burgess, B. (2002). Analyzing qualitative data. Routledge: Library relevant to the HR MDS.
Friese, S. (2012). ATLAS. ti 7 user manual. Berlin: ATLAS ti Scientific Software Development GmbH.
Google Scholar
The World Health Organization Quality of Life Assessment (WHOQOL). (1998). Development and general psychometric properties. Soc Sci Med, 46(12), 1569–1585.
Article
Google Scholar
Koller, M., & Group EULCM. (2016). Update of the EORTC questionnaire for assessing quality of life in patients with lung cancer: Introducing the new EORTC QLQ-LC29. Journal of Clinical Oncology, 34(15_suppl), e18096.
Article
Google Scholar
Yadegarfar, G., Friend, L., Jones, L., Plum, L. M., Ardill, J., Taal, B., et al. (2013). Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. British Journal Of Cancer, 108, 301.
Article
CAS
Google Scholar
Greenberg, P. L., Tuechler, H., Schanz, J., et al. (2012). Revised international prognostic scoring system for myleodysplastic syndromes. Blood, 120(12), 2454–2465.
Article
CAS
Google Scholar
van de Poll-Franse, L., Oerlemans, S., Bredart, A., Kyriakou, C., Sztankay, M., Pallua, S., et al. (2018). International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia. Quality of Life Research, 27(2), 333–345.
Article
Google Scholar
Petersen, M. A., Giesinger, J. M., Holzner, B., Arraras, J. I., Conroy, T., Gamper, E.-M., et al. (2013). Psychometric evaluation of the EORTC computerized adaptive test (CAT) fatigue item pool. Quality of Life Research, 22(9), 2443–2454.
Article
Google Scholar
Gamper, E.-M., Petersen, M. A., Aaronson, N., Costantini, A., Giesinger, J. M., Holzner, B., et al. (2016). Development of an item bank for the EORTC role functioning computer adaptive test (EORTC RF-CAT). Health and Quality of Life Outcomes, 14(1), 72.
Article
Google Scholar
Chen, S.-Y., Pompilus, F., Strzok, S., Cleanthous, S., Cano, S., Marquis, P., et al. (2017). Development of a gait module to complement the 12-item patient-reported multiple sclerosis walking scale. Neurology, 88(16 Supplement), P1. 374.
Google Scholar
Chen, S.-Y., Pompilus, F., Strzok, S., Cleanthous, S., Cano, S., Marquis, P., et al. (2017). Patient-reported outcome measurement in nanual ability for multiple sclerosis: Addressing the targeting issues of the ABILHAND. Neurology, 88(16 Supplement), P3. 364.
Google Scholar